Notice Pursuant to the National Cooperative Research and Production Act of 1993-SAE Consortium Ltd., 62867-62868 [07-5554]

Download as PDF Federal Register / Vol. 72, No. 215 / Wednesday, November 7, 2007 / Notices notice was published in the Federal Register pursuant to Section 6(b) of the Act on July 13, 2007 (72 FR 38618). Patricia A. Brink, Deputy Director of Operations, Antitrust Division. [FR Doc. 07–5562 Filed 11–6–07; 8:45 am] BILLING CODE 4410–11–M DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to The National Cooperative Research and Production Act of 1993—Petroleum Environmental Research Forum Project No. 2004–06 Notice is hereby given that, on March 15, 2007, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Petroleum Environmental Research Forum (‘‘PERF’’) Project No. 2004–06 has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing (1) the identities of the parties to the venture and (2) the nature and objectives of the venture. The notifications were filed for the purpose of invoking the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Pursuant to Section 6(b) of the Act, the identities of the parties to the venture are: BP Products North America Inc., Naperville, IL; Citgo Petroleum Corporation, Lemont, IL; ConocoPhillips Company, bartlesville, OK; Marathon Petroleum Company LLC, Findlay, OH; YPF S.A., Mendoza, ARGENTINA; and Total France, Paris, FRANCE. The general area of PERF Project 2004–06’s planned activity is to reduce desalter environmental impacts. Patricia A. Brink, Deputy Director of Operations, Antitrust Division. [FR Doc. 07–5567 Filed 11–06–07; 8:45 am] BILLING CODE 4410–11–M DEPARTMENT OF JUSTICE pwalker on PROD1PC71 with NOTICES Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Portland Cement Association Notice is hereby given that, on September 6, 2007, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, VerDate Aug<31>2005 19:26 Nov 06, 2007 Jkt 214001 15 U.S.C. 4301, et seq. (‘‘the Act’’), Portland Cement Association (‘‘PCA’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Praxair, Inc., Danbury, CT, has become an Associate Member. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and PCA intends to file additional written notifications disclosing all changes in membership. On January 7, 1985, PCA filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on February 5, 1985 (50 FR 5015). The last notification was filed with the Department on May 14, 2007. A notice as published in the Federal Register pursuant to Section 6(b) of the Act on July 13, 2007 (72 FR 38619). Patricia A. Brink, Deputy Director of Operations, Antitrust Division. [FR Doc. 07–5563 Filed 11–6–07; 8:45 am] BILLING CODE 4410–11–M DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—PXI Systems Alliance, Inc. Notice is hereby given that, on August 7, 2007, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301, et seq. (‘‘the Act’’), PXI Systems Alliance, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Invisar, Inc., Chapel Hill, NC; and Triple E Corporation, Lowell, MA have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 62867 project remains open, and PXI Systems Alliance, Inc. intends to file additional written notifications disclosing all changes in membership. On November 22, 2000, PXI Systems Alliance, Inc. filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on March 8, 2001 (66 FR 13971). The last notification was filed with the Department on May 30, 2007. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on July 13, 2007 (72 FR 38619). Patricia A. Brink, Deputy Director of Operations, Antitrust Division. [FR Doc. 07–5560 Filed 11–6–07; 8:45 am] BILLING CODE 4410–11–M DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—SAE Consortium Ltd. Notice is hereby given that, on September 27, 2007, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), SAE Consortium Ltd. (‘‘SAEC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing (1) the identities of the parties to the venture and (2) the nature and objectives of the venture. The notifications were filed for the purpose of invoking the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Pursuant to Section 6(b) of the Act, the identities of the parties to the venture are: Abbott Laboratories, Abbott Park, IL; F. Hoffmann-La Roche, Inc., Basel, SWITZERLAND; Johnson & Johnson Pharmaceutical Research & Development, LLC, Raritan, NJ; Pfizer, Inc., New York, NY; Sanofi-Aventis, Bridgewater, NJ; SmithKline Beecham Corporation d/b/a GlaxoSmithKline, Research Triangle Park, NC; and Wyeth Pharmaceuticals Inc., Collegeville, PA. The SAEC’s general area of planned activities is to carry out scientific research in the public interest, including research directed toward the discovery of DNA-variants that are clinically useful in understanding and predicting the risk of drug induced serious adverse events and similar scientific research, the results of which E:\FR\FM\07NON1.SGM 07NON1 62868 Federal Register / Vol. 72, No. 215 / Wednesday, November 7, 2007 / Notices will then be made freely available to the public on a nondiscriminatory basis. The venture will enable SAEC to identify DNA-variants useful in understanding and predicting the risk of drug induced serious adverse events with shared financial risk and without the duplication of effort that would result from the work of individual members. As the research results are gathered, they will be placed in the public domain for use by the worldwide medical research community in identifying specific genes involved in causing serious adverse events, thereby facilitating downstream research and development of therapeutic diagnostic and pharmaceutical products. Patricia A. Brink, Deputy Director of Operations, Antitrust Division. [FR Doc. 07–5554 Filed 11–06–07; 8:45 am] intends to file additional written notifications disclosing all changes in membership. On May 27, 2003, Semiconductor Test Consortium, Inc. filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on June 17, 2003 (68 FR 35913). The last notification was filed with the Department on June 7, 2007. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on July 13, 2007 (72 FR 38619). Patricia A. Brink, Deputy Director of Operations, Antitrust Division. [FR Doc. 07–5552 Filed 11–6–07; 8:45 am] BILLING CODE 4410–11–M DEPARTMENT OF JUSTICE BILLING CODE 4410–11–M Antitrust Division DEPARTMENT OF JUSTICE Antitrust Division pwalker on PROD1PC71 with NOTICES Notice Pursuant to the National Cooperative Research and Production Act of 1993—Semiconductor Test Consortium, Inc. Notice is hereby given that, on August 22, 2007, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301, et seq. (‘‘the Act’’), Semiconductor Test Consortium, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Tom Jackson (individual member), Merrimack, NH; Wavecrest Corporation, Eden Prairie, MN; Keven Fetterly (individual member), Rollingbay, WA; and Mark Roos (individual member), Santa Clara, CA have been added as parties to this venture. Also, NXP Semiconductors, Inc., San Jose, CA; John Rowe (individual member), Boston, MA; Christopher Alderson (individual member), Yokohama, JAPAN; Apria Technology, Rollingbay, WA; and Roos Instruments, Santa Clara, CA have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Semiconductor Test Consortium, Inc. VerDate Aug<31>2005 16:14 Nov 06, 2007 Jkt 214001 Notice Pursuant to the National Cooperative Research and Production Act of 1993—Cooperative Research Group on High Efficiency Dilute Gasoline Engine (HEDGE) Notice is hereby given that, on June 1, 2007, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Southwest Research Institute (‘‘SwRI’’): Cooperative Research Group on High Efficiency Dilute Gasoline Engine (‘‘HEDGE’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Honda R&D Co., Ltd, Tochigi Prefecture, JAPAN has been added as a party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and HEDGE intends to file additional written notifications disclosing all changes in membership. On June 10, 2005, HEDGE filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on July 7, 2005 (70 FR 39339– 39340). The last notification was filed with the Department on April 5, 2007. A PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 notice was published in the Federal Register pursuant to Section 6(b) of the Act on May 7, 2007 (72 FR 25782). Patricia A. Brink, Deputy Director of Operations, Antitrust Division. [FR Doc. 07–5559 Filed 11–6–07; 8:45 am] BILLING CODE 4410–11–M DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Cooperative Research Group on Common Rail Fuel Systems Notice is hereby given that, on August 15, 2007, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Southwest Research Institute (‘‘SwRI’’): Cooperative Research Group on Common Rail Fuel Systems filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing (1) the identities of the participants in the cooperative research project and (2) the nature and objectives of the venture. The notifications were filed for the purpose of invoking the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Pursuant to Section 6(b) of the Act, the identities of the current participants in the Cooperative Research Group on Common Rail Fuel Systems are: Baldwin Filters, Kearney, NE; Caterpillar, Inc., Mossville, IL; Champion Laboratories, Inc., Albion, IL; Donaldson, Minneapolis, MN; Komatsu, Oyamo-shi, Japan; Racor, Modesto, Ca. The purpose and nature of the Cooperative Research Group on Common Rail Fuel Systems is to determine the filtration requirements needed to control significant abrasive wear, and to determine the most sensitive areas in the fuel injection system to identify critical components. To attain such, a filtration assessment system and test protocol for testing future systems will be developed. The test protocol will include conditions, such as vibration, to determine environmental factors that may affect the protocol and the protocol will be verified by different degrees of filtration using various common rail systems. A standardized filter test method to meet industry standards will also be recommended. Membership in this research group remains open, and the participants E:\FR\FM\07NON1.SGM 07NON1

Agencies

[Federal Register Volume 72, Number 215 (Wednesday, November 7, 2007)]
[Notices]
[Pages 62867-62868]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-5554]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--SAE Consortium Ltd.

    Notice is hereby given that, on September 27, 2007, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), SAE Consortium Ltd. 
(``SAEC'') has filed written notifications simultaneously with the 
Attorney General and the Federal Trade Commission disclosing (1) the 
identities of the parties to the venture and (2) the nature and 
objectives of the venture. The notifications were filed for the purpose 
of invoking the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances.
    Pursuant to Section 6(b) of the Act, the identities of the parties 
to the venture are: Abbott Laboratories, Abbott Park, IL; F. Hoffmann-
La Roche, Inc., Basel, SWITZERLAND; Johnson & Johnson Pharmaceutical 
Research & Development, LLC, Raritan, NJ; Pfizer, Inc., New York, NY; 
Sanofi-Aventis, Bridgewater, NJ; SmithKline Beecham Corporation d/b/a 
GlaxoSmithKline, Research Triangle Park, NC; and Wyeth Pharmaceuticals 
Inc., Collegeville, PA. The SAEC's general area of planned activities 
is to carry out scientific research in the public interest, including 
research directed toward the discovery of DNA-variants that are 
clinically useful in understanding and predicting the risk of drug 
induced serious adverse events and similar scientific research, the 
results of which

[[Page 62868]]

will then be made freely available to the public on a nondiscriminatory 
basis. The venture will enable SAEC to identify DNA-variants useful in 
understanding and predicting the risk of drug induced serious adverse 
events with shared financial risk and without the duplication of effort 
that would result from the work of individual members. As the research 
results are gathered, they will be placed in the public domain for use 
by the worldwide medical research community in identifying specific 
genes involved in causing serious adverse events, thereby facilitating 
downstream research and development of therapeutic diagnostic and 
pharmaceutical products.

Patricia A. Brink,
Deputy Director of Operations, Antitrust Division.
[FR Doc. 07-5554 Filed 11-06-07; 8:45 am]
BILLING CODE 4410-11-M